Webinar: The Ryan White Program Opiate Epidemic Response in WV
![RWP Opioid Response SE Final AETC 10-19](https://www.seaetc.com/wp-content/uploads/2019/10/RWP-Opioid-Response-SE-Final-AETC-10-19.jpg)
Facilitated by Christine Teague, PharmD, MPH, AAHIVP
Clinical Pharmacist Specialist
CAMC Ryan White HIV Program Director
October 23, 2019
Other Trainings
- Webinar: HIV, HCV and Infection Prevention – Considerations for the Care of Persons Who Inject Drugs
- Webinar: HIV/HCV/HBV Co-infection
- Webinar: Hepatitis A-E
- Webinar: HIV/HBV/HCV co-infection
- Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs
Objectives
- Discuss the emerging Hepatitis C and HIV outbreaks in southern West Virginia
- Describe three strategies to reduce harm associated with IDU in comprehensive outpatient HIV care clinics
- Identify the challenges associated with implementation of community-based public health syringe services programs in rural areas
Presentation
Slides
![RWP Opioid Response SE Final AETC 10-19](https://www.seaetc.com/wp-content/uploads/2019/10/RWP-Opioid-Response-SE-Final-AETC-10-19.jpg)
Facilitated by Christine Teague, PharmD, MPH, AAHIVP
Clinical Pharmacist Specialist
CAMC Ryan White HIV Program Director
October 23, 2019
Objectives
- Discuss the emerging Hepatitis C and HIV outbreaks in southern West Virginia
- Describe three strategies to reduce harm associated with IDU in comprehensive outpatient HIV care clinics
- Identify the challenges associated with implementation of community-based public health syringe services programs in rural areas
Presentation
Slides
Other Trainings
- Webinar: HIV, HCV and Infection Prevention – Considerations for the Care of Persons Who Inject Drugs
- Webinar: HIV/HCV/HBV Co-infection
- Webinar: Hepatitis A-E
- Webinar: HIV/HBV/HCV co-infection
- Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs
![RWP Opioid Response SE Final AETC 10-19](https://www.seaetc.com/wp-content/uploads/2019/10/RWP-Opioid-Response-SE-Final-AETC-10-19.jpg)
Facilitated by Christine Teague, PharmD, MPH, AAHIVP
Clinical Pharmacist Specialist
CAMC Ryan White HIV Program Director
October 23, 2019
Objectives
- Discuss the emerging Hepatitis C and HIV outbreaks in southern West Virginia
- Describe three strategies to reduce harm associated with IDU in comprehensive outpatient HIV care clinics
- Identify the challenges associated with implementation of community-based public health syringe services programs in rural areas
Presentation
Slides
Other Trainings
- Webinar: HIV, HCV and Infection Prevention – Considerations for the Care of Persons Who Inject Drugs
- Webinar: HIV/HCV/HBV Co-infection
- Webinar: Hepatitis A-E
- Webinar: HIV/HBV/HCV co-infection
- Webinar: Emergency Department Testing Unmasks the Hidden Faces of the HCV Epidemic & Identifies Communities at Risk for an Outbreak of HIV Among Persons Who Inject Drugs